क्लिनिकल परीक्षण जर्नल
खुला एक्सेस

अमूर्त

Research Project Management on Clinical Trials-2

Salem Alsuwaidan*

INVESTIGATOR shall perform each Project in accordance with the terms and conditions of this Agreement. The financial support given by SPONSOR to the INVESTIGATOR pursuant to this Agreement shall not be exclusive. INSTITUTION shall assume the legal responsibility attached to the SPONSOR capacity as it results in particular from Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001, and from national laws and regulations, with respect to patients and the Saudi Arabia health authority (SFDA) for trials carried out by INVESTIGATOR. The Investigator’s work is essential to the Study to be performed under this Agreement. INSTITUTION shall notify SPONSOR of any proposed change of the Investigator. If Investigator decides to leave Institution, SPONSOR may either consent to the designation of a new Investigator, or arrange for the transfer of the Study to Investigator’s new institution. Other investigators may not be substituted nor can substantial changes in the level of effort be made without the prior written approval of SPONSOR. INSTITUTION and the INVESTIGATOR agree to grant SPONSOR certain rights to the data (or samples) and the results generated under the Study as provided for herein.